Australia's ADHD therapeutics market is expected to witness growth from $355 Mn in 2022 to $707 Mn in 2030 with a CAGR of 9% for the year 2022-30. The increasing prevalence of ADHD in Australia and the rise in demand for innovative treatment options for its treatment and more investments by pharmaceutical companies in ADHD drugs are the potential growth drivers for the market. The Australia ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Zucero Therapeutics, Atherton Pharmaceuticals, and Novartis are the major players operating in the market.
Australia Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market size is at around $355 Mn in 2022 and is projected to reach $707 Mn in 2030, exhibiting a CAGR of 9% during the forecast period. A total of $105.8 Bn, or 16.8% of total government expenditures in Australia, is projected to be spent on health in 2022–2023. In 2022–2023, the Australian Government's Pharmaceutical Benefits Scheme (PBS) medicine payments will account for the majority of the $17.2 Bn, or 16.3%, in pharmaceutical benefits and services. To support the proposals of the Strengthening Medicare Taskforce, which are due by the end of this year, the government has set aside $750 Mn for its Strengthening Medicare Fund.
Attention deficit hyperactivity disorder is a developmental disorder that starts in childhood. Children with ADHD may struggle to focus and become hyperactive, to the point where the condition interferes with their schoolwork, friendships, or family life. One in twenty Australians suffers from ADHD. Boys are more likely to have it. More than 3 out of 4 kids who are diagnosed with ADHD still exhibit the symptoms as adults. Executive functioning, or the capacity to self-regulate and control ideas, words, actions, and emotions, is impacted by ADHD.
Depending on the particular requirements of each child and family, there are multiple options for treating ADHD. Utilizing effective parenting techniques is frequently the first move. Maintaining a routine, assisting the kid in developing social skills, and working with the school to create a learning environment can all be beneficial. A combination of treatments including medication, psychotherapy, education, and knowledge treatments for adults can include medication, psychotherapy, education, or training in Australia. Both short-acting and long-acting medicines are available in Australia in a variety of forms. The most popular and well-known ADHD treatments are stimulants. When taking these quick-acting drugs, between 70 and 80 % of kids with ADHD experience reduced ADHD symptoms. In 2003, non-stimulants were authorized for the therapy of ADHD. Although they don't work as rapidly as stimulants, they can still have an impact for up to 24 hours. The most frequently recommended medications for ADHD are the stimulants methylphenidate and dexamphetamine in Australia. For some individuals, second-line treatments like tricyclic antidepressants, clonidine, moclobemide, and thioridazine have been used alone or in conjunction with a stimulant. The effectiveness of the other drugs has not yet been determined, despite the tricyclics having a comparable efficacy to that of the stimulants.
Market Growth Drivers
Due to an increase in the number of diagnosed cases, there has been a steady rise in the demand for ADHD medications in Australia. In response to this, the Australia ADHD therapeutics market has expanded as pharmaceutical firms have introduced new medications to meet the rising demand. The treatment choices for ADHD have significantly improved, primarily due to the development of long-acting drugs and non-pharmacological therapies. Because patients and healthcare professionals now have more choices for treating the disorder, this has helped the Australia ADHD therapeutics market to expand.
The reasons most likely to impede the growth of the Australia attention-deficit hyperactivity disorder (ADHD) market in the upcoming years are the strict administration and governing procedures, the rise in drug prices, and the insufficient availability of non-stimulants medicines for ADHD. The quality of life of patients is also being restricted by the contraindications and side effects associated with ADHD medications, which is predicted to further hinder the expansion of the Australia ADHD therapeutics market in the near future.
A drug must be approved by the Therapeutic Goods Administration (TGA) before it can be sold in Australia. Following the 1991 Baume report, the TGA's duties were rearranged. The TGA must assess the drugs' effectiveness, safety, and quality as well as their timely availability. Referrals to the Australian Drug Evaluation Committee (ADEC) are made for new chemical substances and applications that call for professional counsel. The TGA ultimately decides whether to register a drug for use in Australia, despite the ADEC's ability to make suggestions in this regard. The TGA is in charge of examining non-prescription medications, over-the-counter drugs, alternative medicines, and medical equipment in addition to prescription drugs. Drug regulation is a labor- and resource-intensive procedure. Regarding the quality, security, and effectiveness of medications made accessible in Australia, it must be held accountable. The acceptance of a balance between safety and effectiveness is a part of this responsibility.
Recently the Pharmaceutical Benefits Scheme (PBS) removed the age restriction (previously 18 years) to enable people over the age of 18 to be eligible to have a PBS Script for the treatment of ADHD.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
220.127.116.11 Product Applications and Services
18.104.22.168 Recent Developments
22.214.171.124 Partnerships Ecosystem
126.96.36.199 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Drug Type (Revenue, USD Billion):
By Age Group (Revenue, USD Billion):
By Distribution Channel (Revenue, USD Billion):
By Psychotherapy (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses